Transgenic Group (TSE:2342) Beneish M-Score: -2.51 (As of Jun. 28, 2026)


TSE:2342 Transgenic Group Inc TSE:2342
59 GF Score
Price 円207.00
GF Value 円257.18
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group Beneish M-Score?

Transgenic Group TSE:2342 -0.96% 59 Beneish M-Score is -2.51 as of Jun. 28, 2026. GuruFocus rates TSE:2342 with a GF Score™ of 59/100 and a GF Value™ of 円257.18 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 829 Biotechnology companies, Transgenic Group ranks better than 56.45% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.51 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Transgenic Group's Beneish M-Score or its related term are showing as below:

TSE:2342' s Beneish M-Score Range Over the Past 10 Years
Min: -3.37   Med: -2.62   Max: -1.25
Current: -2.51

During the past 13 years, the highest Beneish M-Score of Transgenic Group was -1.25. The lowest was -3.37. And the median was -2.62.


Transgenic Group Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Transgenic Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group Beneish M-Score Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.78 -1.25 -1.98 -3.37 -2.51

Transgenic Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.98 0.00 -3.37 0.00 -2.51

TSE:2342 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Transgenic Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transgenic Group Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Transgenic Group's Beneish M-Score falls into.


TSE:2342
59GF Score
Transgenic Group Inc TSE:2342
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgenic Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Transgenic Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.921+0.528 * 0.9019+0.404 * 1.2243+0.892 * 1.013+0.115 * 1.4527
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.010598-0.327 * 1.0214
=-2.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was 円1,115 Mil.
Revenue was 円13,174 Mil.
Gross Profit was 円2,434 Mil.
Total Current Assets was 円6,709 Mil.
Total Assets was 円9,735 Mil.
Property, Plant and Equipment(Net PPE) was 円1,992 Mil.
Depreciation, Depletion and Amortization(DDA) was 円156 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円3,848 Mil.
Long-Term Debt & Capital Lease Obligation was 円953 Mil.
Net Income was 円-77 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円26 Mil.
Total Receivables was 円1,195 Mil.
Revenue was 円13,005 Mil.
Gross Profit was 円2,167 Mil.
Total Current Assets was 円6,699 Mil.
Total Assets was 円9,586 Mil.
Property, Plant and Equipment(Net PPE) was 円2,055 Mil.
Depreciation, Depletion and Amortization(DDA) was 円242 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円3,272 Mil.
Long-Term Debt & Capital Lease Obligation was 円1,356 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1114.914 / 13174.425) / (1195.011 / 13005.126)
=0.084627 / 0.091888
=0.921

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2166.787 / 13005.126) / (2433.712 / 13174.425)
=0.16661 / 0.18473
=0.9019

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (6708.698 + 1991.612) / 9735.359) / (1 - (6698.896 + 2055.021) / 9586.399)
=0.106319 / 0.08684
=1.2243

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=13174.425 / 13005.126
=1.013

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(241.796 / (241.796 + 2055.021)) / (155.603 / (155.603 + 1991.612))
=0.105274 / 0.072467
=1.4527

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 13174.425) / (0 / 13005.126)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((952.556 + 3848.433) / 9735.359) / ((1356.401 + 3272.076) / 9586.399)
=0.49315 / 0.482817
=1.0214

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-77.267 - 0 - 25.91) / 9735.359
=-0.010598

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Transgenic Group has a M-score of -2.51 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.51 mean?
Transgenic Group (TSE:2342) has a Beneish M-Score of -2.51 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Transgenic Group and its competitors. According to the industry distribution chart, Transgenic Group ranks #361 out of 829 companies in the Biotechnology industry, placing it in the top 43.5%.
Is Transgenic Group's Beneish M-Score too high?
Transgenic Group's current Beneish M-Score is -2.51. Based on the distribution chart, Transgenic Group ranks #361 out of 829 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Transgenic Group has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Transgenic Group ranks #361 out of 829 companies for Beneish M-Score. This puts Transgenic Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Transgenic Group and its competitors. Transgenic Group's current Beneish M-Score is -2.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.18, compared to a current price of 円207.00 — trading 19.5% below its estimated fair value. The current Beneish M-Score is -2.51. Transgenic Group's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Beneish M-Score is -2.51 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued. The current stock price of 円207.00 is trading 19.5% below its estimated GF Value™ of 円257.18. GuruFocus considers Transgenic Group to be Modestly Undervalued.

Key valuation signals for TSE:2342:

  • Beneish M-Score: -2.51
  • GF Value™: 円257.18 vs. price of 円207.00 (19.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
59GF Score

Get the complete analysis for TSE:2342

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円207.00
Price
円257.18
GF Value